These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 19228222)

  • 1. Comparison between two functional assays to detect factor V Leiden.
    Gessoni G; Valverde S; Manoni F
    Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e188-9. PubMed ID: 19228222
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of Russell viper venom-based and activated partial thromboplastin time-based screening assays for resistance to activated protein C.
    Herskovits AZ; Lemire SJ; Longtine J; Dorfman DM
    Am J Clin Pathol; 2008 Nov; 130(5):796-804. PubMed ID: 18854273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of a functional prothrombin time-based assay for identification of factor V Leiden carriers in a group of Italian patients with venous thrombosis.
    Gessoni G; Valverde S
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):603-10. PubMed ID: 17890946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated protein C resistance and lupus anticoagulant in pregnancy.
    Busowski JD; Jenkins AD; Hale EU; Busowski M; Dacus JV
    J Matern Fetal Med; 1999; 8(6):298-9. PubMed ID: 10582865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of a new functional test for detection of activated protein C resistance (Pefakit APC-R Factor V Leiden) at two centers in Europe and the USA.
    Schöni R; Quehenberger P; Wu JR; Wilmer M
    Thromb Res; 2007; 119(1):17-26. PubMed ID: 16934314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 2-year retrospective analysis of laboratory testing for activated protein C resistance with a factor V-corrected activated partial thromboplastin time-based method.
    De Bel AV; Van der Cruyssen GA; Devreese KM
    Blood Coagul Fibrinolysis; 2006 Mar; 17(2):155-60. PubMed ID: 16479199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural coagulation inhibitory proteins and activated protein C resistance in Turkish patients with inflammatory bowel disease.
    Payzin B; Adakan FY; Yalçin HC; Cetinkaya GS; Berkmen S; Eraslan S; Unsal B
    Turk J Gastroenterol; 2006 Sep; 17(3):183-90. PubMed ID: 16941251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated protein C resistance assay and factor V Leiden.
    Prüller F; Weiss EC; Raggam RB; Cervar-Zivkovic M; Renner W; Wagner J; Michaelis S; März W; Mangge H
    N Engl J Med; 2014 Aug; 371(7):685-6. PubMed ID: 25119624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of resistance against activated protein C resulting from factor V Leiden is significantly increased in myocardial infarction: investigation of 507 patients with myocardial infarction.
    Middendorf K; Göhring P; Huehns TY; Seidel D; Steinbeck G; Nikol S
    Am Heart J; 2004 May; 147(5):897-904. PubMed ID: 15131548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of three reactants for the detection of activated protein C resistance due to mutation of factor V Leiden during pregnancy].
    Magdelaine A; Soubrier F; Berkane N; Uzan S; Verdy E
    Ann Biol Clin (Paris); 1998; 56(4):445-50. PubMed ID: 9754280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated protein C resistance and factor V Leiden in Mexico.
    Majluf-Cruz A; Moreno-Hernández M; Ruiz-de-Chávez-Ochoa A; Monroy-García R; Majluf-Cruz K; Guardado-Mendoza R; Molina-Avila I; Isordia-Salas I; Corona-de la Peña N; Vargas-Vorackova F; Vela-Ojeda J; García-Chávez J
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):428-37. PubMed ID: 18160617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of acquired resistance to activated protein C associated with antiphospholipid antibodies using a novel clotting assay.
    Gardiner C; Cohen H; Jenkins A; Machin SJ; Mackie IJ
    Blood Coagul Fibrinolysis; 2006 Sep; 17(6):477-83. PubMed ID: 16905952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional activated protein C resistance assays: correlation with factor V DNA analysis is better with RVVT-than APTT-based assays.
    Favaloro EJ; Mirochnik O; McDonald D
    Br J Biomed Sci; 1999; 56(1):23-33. PubMed ID: 10492912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of dabigatran and rivarovaban on a prothrombinase-based assay for activated protein C resistance: a preliminary study in subjects heterozygous for factor V Leiden.
    Gessoni G; Valverde S; Gessoni F; Valle R
    Blood Transfus; 2015 Oct; 13(4):666-8. PubMed ID: 25761318
    [No Abstract]   [Full Text] [Related]  

  • 15. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
    Viveros ME; Cabiedes J; Reyes E; Cabral AR
    Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of factor V Leiden in the Chinese population.
    Ho CH; Chau WK; Hsu HC; Gau JP; Chih CM
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Dec; 62(12):875-8. PubMed ID: 10634001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of factor V Leiden mutation in Yugoslav thrombophilic patients and its relationship to the laboratory diagnosis of APC resistance.
    Mikovic D; Rakicevic L; Kovac M; Radojkovic D
    Thromb Haemost; 2000 Oct; 84(4):723-4. PubMed ID: 11057877
    [No Abstract]   [Full Text] [Related]  

  • 18. Arterial vascular occlusion associated with factor V Leiden gene mutation.
    Tayyanipour R; Pulido JS; Postel EA; Lipkowitz JL; Pisciotta A; Braza E
    Retina; 1998; 18(4):376-7. PubMed ID: 9730184
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of an activated partial thromboplastin time with a Russell viper venom time test in screening for factor V(Leiden) (FVR506Q).
    Sweeney JD; Blair AJ; King TC
    Am J Clin Pathol; 1997 Jul; 108(1):74-7. PubMed ID: 9208981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recommendations for clinical laboratory testing of activated protein C resistance; communication from the SSC of the ISTH.
    Moore GW; Van Cott EM; Cutler JA; Mitchell MJ; Adcock DM;
    J Thromb Haemost; 2019 Sep; 17(9):1555-1561. PubMed ID: 31317658
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.